Nordea Investment Management
GHDX

Nordea Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Nordea Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-68,916
Closed -$4.01M – 996
2019
Q2 		$4.01M Sell
68,916
-3,540
-5% -$210K 0.01% 590
2019
Q1 		$5.08M Buy
72,456
+946
+1% +$70.1K 0.01% 568
2018
Q4 		$4.61M Sell
71,510
-7,618
-10% -$534K 0.01% 532
2018
Q3 		$5.56M Buy
79,128
+11,776
+17% +$689K 0.01% 523
2018
Q2 		$3.4M Sell
67,352
-28,458
-30% -$1.13M 0.01% 562
2018
Q1 		$3M Buy
95,810
+15,097
+19% +$501K 0.01% 607
2017
Q4 		$2.76M Buy
80,713
+11,901
+17% +$379K 0.01% 531
2017
Q3 		$2.21M Buy
68,812
+10,787
+19% +$340K 0.01% 634
2017
Q2 		$1.89M Buy
58,025
+4,418
+8% +$140K ﹤0.01% 651
2017
Q1 		$1.69M Buy
53,607
+11,970
+29% +$354K ﹤0.01% 604
2016
Q4 		$1.22M Hold
41,637
– – ﹤0.01% 676
2016
Q3 		$1.2M Buy
41,637
+17,579
+73% +$490K ﹤0.01% 596
2016
Q2 		$623K Buy
+24,058
New +$639K ﹤0.01% 677

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Nordea Investment Management's GHDX Position: Q3 2019 in Review

Nordea Investment Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 68,916 shares — an estimated $4.01M sold.

Nordea Investment Management first reported a position in GHDX in Q2 2016 and held it in 13 quarters. The position peaked at $5.56M in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Nordea Investment Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Nordea Investment Management sold 68,916 Genomic Health, Inc. shares in Q3 2019, an estimated $4.01M.
  • Nordea Investment Management first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 13 quarters.
  • Nordea Investment Management's Genomic Health, Inc. position peaked at $5.56M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Nordea Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.